← Evidence map

ArticleBlood advances2023

CNL and aCML should be considered as a single entity based on molecular profiles and outcomes.

Gonzalo Carreño-Tarragona et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

19 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36375042